Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Vaxart (VXRT) has a market cap of $0.19 billion USD. According to our data, Vaxart is ranked No.7177 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.19 B |
23.82%
|
| Dec 31, 2024 | $0.15 B |
15.79%
|
| Dec 29, 2023 | $0.13 B |
-40.62%
|
| Dec 30, 2022 | $0.22 B |
-84.69%
|
| Dec 31, 2021 | $1.43 B |
9.81%
|
| Dec 31, 2020 | $1.30 B |
1,531.43%
|
| Dec 31, 2019 | $79.62 M |
-81.38%
|
| Dec 31, 2018 | $0.43 B |
-70.02%
|
| Dec 29, 2017 | $1.43 B |
-53.66%
|
| Dec 30, 2016 | $3.08 B |
-36.60%
|
| Dec 31, 2015 | $4.85 B |
-13.39%
|
| Dec 31, 2014 | $5.61 B |
-46.54%
|
| Dec 31, 2013 | $10.48 B |
5.01%
|
| Dec 31, 2012 | $9.98 B |
-60.58%
|
| Dec 30, 2011 | $25.33 B |
-67.53%
|
| Dec 31, 2010 | $78.01 B |
18.16%
|
| Dec 31, 2009 | $66.02 B |
46.27%
|
| Dec 31, 2008 | $45.14 B |
-7.20%
|
| Dec 31, 2007 | $48.64 B |
-46.76%
|
| Dec 29, 2006 | $91.35 B |
100.59%
|
| Dec 30, 2005 | $45.54 B |
-76.93%
|
| Dec 31, 2004 | $197.39 B |
15.26%
|
| Dec 31, 2003 | $171.25 B |
105.00%
|
| Dec 31, 2002 | $83.54 B |
-39.92%
|
| Dec 31, 2001 | $139.05 B |
123.14%
|
| Dec 29, 2000 | $62.31 B |
0.00%
|
| Dec 31, 1999 | $62.31 B |
72.09%
|
| Dec 31, 1998 | $36.21 B |
-21.10%
|
| Dec 31, 1997 | $45.89 B |
-61.07%
|
| Dec 31, 1996 | $117.89 B |
-18.60%
|
| Dec 29, 1995 | $144.84 B |
43.33%
|
| Dec 30, 1994 | $101.05 B |
126.42%
|
| Dec 31, 1993 | $44.63 B |
17.78%
|
| Dec 31, 1992 | $37.89 B |
-15.09%
|
| Dec 31, 1991 | $44.63 B |
253.33%
|
| Dec 31, 1990 | $12.63 B |
0.00%
|
| Dec 29, 1989 | $12.63 B |
11.11%
|
| Dec 30, 1988 | $11.37 B |
-20.59%
|
| Dec 31, 1987 | $14.32 B |
-22.73%
|
| Dec 31, 1986 | $18.53 B |
37.50%
|
| Dec 31, 1985 | $13.47 B |
0.00%
|
| Dec 31, 1984 | $13.47 B |
-42.86%
|
| Dec 30, 1983 | $23.58 B |
-6.67%
|
| Dec 31, 1982 | $25.26 B |
36.36%
|
| Dec 31, 1981 | $18.53 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
 Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
 BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
 Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
 AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
 Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
 GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
 Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
 Dynavax Technologies
DVAX
|
$1.63 B |
-0.000 M
|
USA
|
 Arcturus Therapeutics
ARCT
|
$0.45 B |
0.000 M
|
USA
|
 Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
 Altimmune
ALT
|
$0.49 B |
0.000 M
|
USA
|
 Tonix Pharmaceuticals
TNXP
|
$59.62 M |
0.000 M
|
USA
|
| Market Cap | = | VXRT Stock Price | * | VXRT Shares Outstanding |
| = | $0.82 | * | 0.23 B | |
| = | $0.19 B |